S&P/TSX Composite Index Ends the Week 2.65% Higher at 20175.77 — Data Talk
The S&P/TSX Composite Index is up 521.30 points or 2.65% this week to 20175.77
--Up two of the past three weeks
--Today it is up 122.70 points or 0.61%.
--Up six of the past seven trading days
--Off 8.65% from its record close of 22087.22 hit Tuesday, March 29, 2022.
--Highest closing value since Wednesday, Sept. 20, 2023.
--Off 2.85% from its 52-week high of 20767.38 hit Tuesday, Jan. 31, 2023.
--Up 7.68% from its 52-week low of 18737.39 hit Friday, Oct. 27, 2023.
--Rose 0.98% from 52 weeks ago.
--Off 2.85% from its 2023 closing high of 20767.38 hit Tuesday, Jan. 31, 2023.
--Up 7.68% from its 2023 closing low of 18737.39 hit Friday, Oct. 27, 2023.
--Month-to-date it is up 6.90%.
--Year-to-date it is up 790.85 points or 4.08%.
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 17, 2023 17:49 ET (22:49 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters